Detalhe da pesquisa
1.
PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma.
N Engl J Med
; 374(26): 2542-52, 2016 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-27093365
2.
New directions in cellular therapy of cancer: a summary of the summit on cellular therapy for cancer.
J Transl Med
; 10: 48, 2012 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22420641
3.
Twelve immunotherapy drugs that could cure cancers.
Immunol Rev
; 222: 357-68, 2008 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-18364014
4.
Pembrolizumab induces HIV latency reversal in people living with HIV and cancer on antiretroviral therapy.
Sci Transl Med
; 14(629): eabl3836, 2022 01 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35080914
5.
Metabolic adaptation of ovarian tumors in patients treated with an IDO1 inhibitor constrains antitumor immune responses.
Sci Transl Med
; 14(636): eabg8402, 2022 03 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35294258
6.
New interpretable machine-learning method for single-cell data reveals correlates of clinical response to cancer immunotherapy.
Patterns (N Y)
; 2(12): 100372, 2021 Dec 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34950900
7.
Immune cell topography predicts response to PD-1 blockade in cutaneous T cell lymphoma.
Nat Commun
; 12(1): 6726, 2021 11 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34795254
8.
Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma.
J Immunother Cancer
; 9(4)2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33879601
9.
Neoadjuvant Selicrelumab, an Agonist CD40 Antibody, Induces Changes in the Tumor Microenvironment in Patients with Resectable Pancreatic Cancer.
Clin Cancer Res
; 27(16): 4574-4586, 2021 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34112709
10.
Pillars article: Eradication of disseminated murine leukemia by chemoimmunotherapy with cyclophosphamide and adoptively transferred immune syngeneic Lyt-1+2- lymphocytes. J. Exp. Med. 1981. 154: 952-963.
J Immunol
; 190(5): 1899-910, 2013 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23417526
11.
Pembrolizumab in Relapsed and Refractory Mycosis Fungoides and Sézary Syndrome: A Multicenter Phase II Study.
J Clin Oncol
; 38(1): 20-28, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31532724
12.
Flt3 ligand augments immune responses to anti-DEC-205-NY-ESO-1 vaccine through expansion of dendritic cell subsets.
Nat Cancer
; 1(12): 1204-1217, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35121932
13.
Translational Research Working Group developmental pathway for immune response modifiers.
Clin Cancer Res
; 14(18): 5692-9, 2008 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18794077
14.
Assessment of the Safety of Pembrolizumab in Patients With HIV and Advanced Cancer-A Phase 1 Study.
JAMA Oncol
; 5(9): 1332-1339, 2019 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31154457
15.
Tuberculosis following PD-1 blockade for cancer immunotherapy.
Sci Transl Med
; 11(475)2019 01 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-30651320
16.
Durable Tumor Regression and Overall Survival in Patients With Advanced Merkel Cell Carcinoma Receiving Pembrolizumab as First-Line Therapy.
J Clin Oncol
; 37(9): 693-702, 2019 03 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30726175
17.
Merkel cell polyomavirus-specific immune responses in patients with Merkel cell carcinoma receiving anti-PD-1 therapy.
J Immunother Cancer
; 6(1): 131, 2018 11 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30482247
18.
Phase I Trial of ALT-803, A Novel Recombinant IL15 Complex, in Patients with Advanced Solid Tumors.
Clin Cancer Res
; 24(22): 5552-5561, 2018 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30045932
19.
A First-in-Human Phase I Study of Subcutaneous Outpatient Recombinant Human IL15 (rhIL15) in Adults with Advanced Solid Tumors.
Clin Cancer Res
; 24(7): 1525-1535, 2018 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29203590
20.
Pembrolizumab in mycosis fungoides with PD-L1 structural variants.
Blood Adv
; 5(3): 771-774, 2021 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33560388